Titre : Rome

Rome : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Rome : Questions médicales les plus fréquentes", "headline": "Rome : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Rome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-19", "dateModified": "2025-05-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Rome" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Italie", "url": "https://questionsmedicales.fr/mesh/D007558", "about": { "@type": "MedicalCondition", "name": "Italie", "code": { "@type": "MedicalCode", "code": "D007558", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.542.489" } } }, "about": { "@type": "MedicalCondition", "name": "Rome", "alternateName": "Rome", "code": { "@type": "MedicalCode", "code": "D012384", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alexander C Ford", "url": "https://questionsmedicales.fr/author/Alexander%20C%20Ford", "affiliation": { "@type": "Organization", "name": "Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK." } }, { "@type": "Person", "name": "Marina Davoli", "url": "https://questionsmedicales.fr/author/Marina%20Davoli", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology of the Lazio Regional Health Service, ASL Roma 1, Rome, Italy." } }, { "@type": "Person", "name": "Christopher J Black", "url": "https://questionsmedicales.fr/author/Christopher%20J%20Black", "affiliation": { "@type": "Organization", "name": "Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK." } }, { "@type": "Person", "name": "Lesley A Houghton", "url": "https://questionsmedicales.fr/author/Lesley%20A%20Houghton", "affiliation": { "@type": "Organization", "name": "Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK." } }, { "@type": "Person", "name": "Yan Yiannakou", "url": "https://questionsmedicales.fr/author/Yan%20Yiannakou", "affiliation": { "@type": "Organization", "name": "County Durham and Darlington NHS Foundation Trust, Durham, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37511475", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241411715" } }, { "@type": "ScholarlyArticle", "name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.", "datePublished": "2023-03-07", "url": "https://questionsmedicales.fr/article/36894035", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1053/j.gastro.2023.02.044" } }, { "@type": "ScholarlyArticle", "name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.", "datePublished": "2023-02-28", "url": "https://questionsmedicales.fr/article/36855007", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12350-023-03202-w" } }, { "@type": "ScholarlyArticle", "name": "Optimal age to stop prostate cancer screening and early detection.", "datePublished": "2023-08-19", "url": "https://questionsmedicales.fr/article/37598870", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcpo.2023.100443" } }, { "@type": "ScholarlyArticle", "name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36121650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijc.34298" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Europe", "item": "https://questionsmedicales.fr/mesh/D005060" }, { "@type": "ListItem", "position": 4, "name": "Italie", "item": "https://questionsmedicales.fr/mesh/D007558" }, { "@type": "ListItem", "position": 5, "name": "Rome", "item": "https://questionsmedicales.fr/mesh/D012384" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Rome - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Rome", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Rome", "description": "Quels sont les critères de Rome pour le diagnostic ?\nComment confirmer un diagnostic selon Rome ?\nLes critères de Rome sont-ils universels ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nLes examens complémentaires sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D012384?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Rome", "description": "Quels sont les symptômes principaux du syndrome de l'intestin irritable ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes symptômes peuvent-ils s'aggraver avec le stress ?\nY a-t-il des symptômes associés à des aliments spécifiques ?\nLes symptômes peuvent-ils disparaître spontanément ?", "url": "https://questionsmedicales.fr/mesh/D012384?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Rome", "description": "Peut-on prévenir le syndrome de l'intestin irritable ?\nLe stress peut-il être prévenu ?\nUne alimentation équilibrée peut-elle prévenir les symptômes ?\nL'exercice physique joue-t-il un rôle préventif ?\nLes consultations médicales régulières sont-elles utiles ?", "url": "https://questionsmedicales.fr/mesh/D012384?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Rome", "description": "Quels traitements sont recommandés pour le syndrome de l'intestin irritable ?\nLes probiotiques sont-ils efficaces ?\nLes médicaments antispasmodiques sont-ils utiles ?\nLa thérapie cognitive-comportementale est-elle bénéfique ?\nLes changements alimentaires sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D012384?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Rome", "description": "Quelles complications peuvent survenir avec le syndrome de l'intestin irritable ?\nLe syndrome peut-il entraîner des maladies graves ?\nLes complications psychologiques sont-elles fréquentes ?\nLe syndrome peut-il affecter la nutrition ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D012384?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Rome", "description": "Quels sont les facteurs de risque du syndrome de l'intestin irritable ?\nLe sexe influence-t-il le risque ?\nL'âge joue-t-il un rôle dans le développement du syndrome ?\nLes antécédents d'infections intestinales augmentent-ils le risque ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D012384?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels sont les critères de Rome pour le diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent des douleurs abdominales récurrentes et des changements dans les habitudes intestinales." } }, { "@type": "Question", "name": "Comment confirmer un diagnostic selon Rome ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est confirmé par l'exclusion d'autres pathologies et l'évaluation des symptômes." } }, { "@type": "Question", "name": "Les critères de Rome sont-ils universels ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont utilisés internationalement pour standardiser le diagnostic des troubles fonctionnels." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les symptômes et à écarter d'autres maladies." } }, { "@type": "Question", "name": "Les examens complémentaires sont-ils nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des examens peuvent être réalisés pour exclure d'autres conditions, mais ne sont pas toujours requis." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux du syndrome de l'intestin irritable ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des ballonnements, et des changements de transit." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la fréquence des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le stress ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes du syndrome de l'intestin irritable." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des aliments spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certains aliments peuvent déclencher des symptômes, comme les produits laitiers ou les fibres." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils disparaître spontanément ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent connaître des périodes de rémission sans traitement." } }, { "@type": "Question", "name": "Peut-on prévenir le syndrome de l'intestin irritable ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider." } }, { "@type": "Question", "name": "Le stress peut-il être prévenu ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de gestion du stress, comme la méditation, peuvent aider à réduire son impact." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle prévenir les symptômes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fibres et pauvre en aliments irritants peut aider." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle préventif ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé digestive et réduire le stress." } }, { "@type": "Question", "name": "Les consultations médicales régulières sont-elles utiles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de surveiller les symptômes et d'ajuster le traitement si nécessaire." } }, { "@type": "Question", "name": "Quels traitements sont recommandés pour le syndrome de l'intestin irritable ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des modifications alimentaires, des médicaments et des thérapies comportementales." } }, { "@type": "Question", "name": "Les probiotiques sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à améliorer certains symptômes, mais les résultats varient." } }, { "@type": "Question", "name": "Les médicaments antispasmodiques sont-ils utiles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent soulager les douleurs abdominales et les crampes associées au syndrome." } }, { "@type": "Question", "name": "La thérapie cognitive-comportementale est-elle bénéfique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à gérer le stress et améliorer la qualité de vie des patients." } }, { "@type": "Question", "name": "Les changements alimentaires sont-ils nécessaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des ajustements alimentaires peuvent réduire les symptômes et améliorer le bien-être." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le syndrome de l'intestin irritable ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anxiété, la dépression et une qualité de vie diminuée." } }, { "@type": "Question", "name": "Le syndrome peut-il entraîner des maladies graves ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, le syndrome de l'intestin irritable n'entraîne pas de maladies graves, mais peut affecter la vie quotidienne." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux patients souffrent d'anxiété ou de dépression en raison de leurs symptômes." } }, { "@type": "Question", "name": "Le syndrome peut-il affecter la nutrition ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les restrictions alimentaires peuvent entraîner des carences nutritionnelles." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un traitement approprié et un suivi régulier peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du syndrome de l'intestin irritable ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le stress, les antécédents familiaux et certains troubles psychologiques." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer le syndrome que les hommes." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le développement du syndrome ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le syndrome peut survenir à tout âge, mais il est plus fréquent chez les jeunes adultes." } }, { "@type": "Question", "name": "Les antécédents d'infections intestinales augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections intestinales antérieures peuvent augmenter le risque de développer le syndrome." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.

Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv... The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro... In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo... EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....

Optimal age to stop prostate cancer screening and early detection.

Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can... We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer... Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the... Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...

Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer.

The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can... This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ... In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst... Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...

Integration of multiomics features for blood-based early detection of colorectal cancer.

Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o... In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me... This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv... Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...

Prospective cohort for early detection of liver cancer (Pearl): a study protocol.

Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir... This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ... Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings.... NCT05541601....